Department of Cancer Genetics, St. Vincent Hospital, 8301 Harcourt Road #100, Indianapolis, IN 46260, USA.
Fam Cancer. 2010 Sep;9(3):377-81. doi: 10.1007/s10689-010-9339-4.
As we learn more about the etiology and cancer risks associated with Lynch syndrome (LS), the phenotypic spectrum of this condition and its genotype-phenotype correlations are being elucidated. We report a patient with past history of multiple cancers including colon and kidney cancer, and recently diagnosed with jejunal adenocarcinoma. The patient had microsatellite instability and immunohistochemistry (MSI/IHC) testing performed on his small bowel cancer in order to evaluate his risk for LS. The MSI/IHC results on his tumor tissue were reported as abnormal and subsequent blood draw revealed the presence of a germline MSH6 mismatch repair gene mutation. This case highlights the phenotypic variability of LS and complications it may present in evaluation for diagnosis and appropriate surveillance and management recommendations. To our knowledge, this is the first report of MSI/IHC being done on small bowel cancer to evaluate for this condition and subsequently confirmed via molecular analysis.
随着我们对林奇综合征(LS)相关病因和癌症风险的了解不断增加,这种病症的表型谱及其基因型-表型相关性正在被阐明。我们报告了一位既往有多发性癌症病史的患者,包括结肠癌和肾癌,最近被诊断患有空肠腺癌。该患者曾接受过小肠癌的微卫星不稳定性和免疫组织化学(MSI/IHC)检测,以评估其 LS 风险。其肿瘤组织的 MSI/IHC 结果报告为异常,随后的血液检测显示存在种系 MSH6 错配修复基因突变。本病例突出了 LS 的表型变异性及其在诊断评估以及适当的监测和管理建议方面可能出现的并发症。据我们所知,这是首例在小肠癌中进行 MSI/IHC 检测以评估该病症的报告,并通过分子分析得到证实。